| Steven Gene Hagen, MD | |
|
550 Osborne Rd Ne, Fridley, MN 55432 | |
| (763) 236-4144 | |
| (763) 236-4900 |
| Full Name | Steven Gene Hagen |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 23 Years |
| Location | 550 Osborne Rd Ne, Fridley, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780651901 | NPI | - | NPPES |
| 46553 | Other | MN MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 46553 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Physicians Professional Association | 9537072657 | 205 |
News Archive
Novartis today announced the US Food and Drug Administration has approved Odomzo (sonidegib, formerly LDE225) 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.
Researchers at the Medical Faculty of the Technische Universität Dresden and the Heinrich Pette Institute, Leibniz Institute for Experimental Virology succeeded in developing a designer recombinase (Brec1) that is capable of specifically removing the provirus from infected cells of most primary HIV-1 isolates.
Excessive alcohol consumption is a global public health issue. In the United States, binge drinking is the most common form - so common, in fact, that the Centers for Disease Control and Prevention reports approximately one in six adults binge drinks about four times each month.
Biosafe is pleased to announce that, in partnership with its Indian Distributor Span Healthcare Private Ltd., it has achieved major expansion of its stem cell banking business in India, winning major new customer deals consecutively.
A team of scientists at the Institut de recherches cliniques de Montr-al (IRCM) led by Dr. Jean-Fran-ois C-t-, Director of the Cytoskeletal Organization and Cell Migration research unit, identified a novel molecular mechanism in the control of cell motility. Their findings were published online today in Current Biology, a journal from the Cell Press group. This scientific breakthrough could eventually lead to the development of new cancer-treating drugs that could block the spread of tumours (metastasis).
› Verified 2 days ago
| Entity Name | Emergency Physicians Professional Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801871934 PECOS PAC ID: 9537072657 Enrollment ID: O20031106000068 |
News Archive
Novartis today announced the US Food and Drug Administration has approved Odomzo (sonidegib, formerly LDE225) 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.
Researchers at the Medical Faculty of the Technische Universität Dresden and the Heinrich Pette Institute, Leibniz Institute for Experimental Virology succeeded in developing a designer recombinase (Brec1) that is capable of specifically removing the provirus from infected cells of most primary HIV-1 isolates.
Excessive alcohol consumption is a global public health issue. In the United States, binge drinking is the most common form - so common, in fact, that the Centers for Disease Control and Prevention reports approximately one in six adults binge drinks about four times each month.
Biosafe is pleased to announce that, in partnership with its Indian Distributor Span Healthcare Private Ltd., it has achieved major expansion of its stem cell banking business in India, winning major new customer deals consecutively.
A team of scientists at the Institut de recherches cliniques de Montr-al (IRCM) led by Dr. Jean-Fran-ois C-t-, Director of the Cytoskeletal Organization and Cell Migration research unit, identified a novel molecular mechanism in the control of cell motility. Their findings were published online today in Current Biology, a journal from the Cell Press group. This scientific breakthrough could eventually lead to the development of new cancer-treating drugs that could block the spread of tumours (metastasis).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven Gene Hagen, MD 7301 Ohms Lane, Suite 650, Edina, MN 55439 Ph: (952) 835-9880 | Steven Gene Hagen, MD 550 Osborne Rd Ne, Fridley, MN 55432 Ph: (763) 236-4144 |
News Archive
Novartis today announced the US Food and Drug Administration has approved Odomzo (sonidegib, formerly LDE225) 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.
Researchers at the Medical Faculty of the Technische Universität Dresden and the Heinrich Pette Institute, Leibniz Institute for Experimental Virology succeeded in developing a designer recombinase (Brec1) that is capable of specifically removing the provirus from infected cells of most primary HIV-1 isolates.
Excessive alcohol consumption is a global public health issue. In the United States, binge drinking is the most common form - so common, in fact, that the Centers for Disease Control and Prevention reports approximately one in six adults binge drinks about four times each month.
Biosafe is pleased to announce that, in partnership with its Indian Distributor Span Healthcare Private Ltd., it has achieved major expansion of its stem cell banking business in India, winning major new customer deals consecutively.
A team of scientists at the Institut de recherches cliniques de Montr-al (IRCM) led by Dr. Jean-Fran-ois C-t-, Director of the Cytoskeletal Organization and Cell Migration research unit, identified a novel molecular mechanism in the control of cell motility. Their findings were published online today in Current Biology, a journal from the Cell Press group. This scientific breakthrough could eventually lead to the development of new cancer-treating drugs that could block the spread of tumours (metastasis).
› Verified 2 days ago
Wendy Laine, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 Osborne Rd Ne, Unity Medical Center, Fridley, MN 55432 Phone: 763-236-4144 Fax: 763-236-4900 | |
Susan Kay Hafferman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Osborne Rd Ne, Unity Hospital, Fridley, MN 55432 Phone: 763-236-4144 Fax: 763-236-4900 | |
Kurt Edward Belk, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 550 Osborne Rd Ne, Unity Medical Center, Fridley, MN 55432 Phone: 763-236-4144 Fax: 763-236-4900 | |
William Carter Keig, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 550 Osborne Rd Ne, Unity Hospital, Fridley, MN 55432 Phone: 763-236-4144 Fax: 763-236-4900 | |
Carolyn A. Mcclain, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Unity Hospital, 550 Osborne Road Ne, Fridley, MN 55432 Phone: 763-236-5000 | |
Ian Mckelvey Moorhead, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 550 Osborne Rd Ne, Unity Hospital, Fridley, MN 55432 Phone: 763-236-4144 Fax: 763-236-4900 |